Physician profile
John M Macdonald
NPI 1912312943
$3,811.71
in general payments reported to CMS, 2019-2025
16 companies · $658 in 2025
The $658 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $338 · 2021: $480 · 2022: $881 · 2023: $573 · 2024: $495 · 2025: $658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,604 · Entertainment: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,604.18 |
| Entertainment | $120.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $953.00 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $863.97 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Bausch & Lomb Americas INC. | $498.98 | 2022-2025 | Infuse, Btod, Xiidra |
| Johnson & Johnson Vision Care, INC. | $412.18 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $338.53 | 2019-2021 | |
| Sight Sciences, INC. | $143.64 | 2022 | |
| Optos, INC. | $120.96 | 2023-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $92.61 | 2024 | |
| Abb Con-Cise Optical Group LLC | $85.08 | 2019-2025 | Contact Lens, Spectacle Lenses |
| Glaukos Corporation | $73.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $68.49 | 2020-2022 | |
| Allergan, INC. | $50.20 | 2021-2022 | |
| Shire North American Group INC | $48.61 | 2019 | |
| Abbvie INC. | $35.09 | 2022 | |
| Kala Pharmaceuticals, INC. | $15.68 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optovue, INC. | $10.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.